Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults (clinicaltrials.gov) - Apr 30, 2025 - P1 | N=160 | Recruiting | Sponsor: Clover Biopharmaceuticals USA, LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections
|